IN VIVO ASSESSMENT OF TOXICITY AND PHARMACOKINETICS OF METHYLGLYOXAL

摘要

A pharmaceutical composition and treatment method to reduce the proliferation of cancerous or tumor cells, in which the combined active agents are methylglyoxal, ascorbic acid, creatine and melatonin.